Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-014860
Filing Date
2021-06-21
Accepted
2021-06-21 16:15:44
Documents
2
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5524
2 ex24-1.htm EX-24.1 11055
  Complete submission text file 0001493152-21-014860.txt   18019
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1300 N. KELLOGG DRIVE, SUITE D ANAHEIM CA 92807
Business Address
Mulroy Michael H. (Reporting) CIK: 0001509725 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12830 | Film No.: 211030741